Blueprint Medicines Corporation (BPMC)
Market Cap | 7.02B |
Revenue (ttm) | 282.21M |
Net Income (ttm) | -288.29M |
Shares Out | 62.62M |
EPS (ttm) | -4.81 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 427,469 |
Open | 115.90 |
Previous Close | 113.69 |
Day's Range | 112.02 - 116.51 |
52-Week Range | 43.89 - 121.90 |
Beta | 0.63 |
Analysts | Buy |
Price Target | 116.33 (+3.69%) |
Earnings Date | Aug 1, 2024 |
About BPMC
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered thyroid carcinoma, and medul... [Read more]
Financial Performance
In 2023, BPMC's revenue was $249.38 million, an increase of 22.22% compared to the previous year's $204.04 million. Losses were -$506.98 million, -9.06% less than in 2022.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for BPMC stock is "Buy." The 12-month stock price forecast is $116.33, which is an increase of 3.69% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/k/v/press4-2549301.jpg)
Blueprint Medicines Corporation Investors Are Notified By The Schall Law Firm Of Ongoing Investigations Into Possible Securities Law Breaches
LOS ANGELES, CA / ACCESSWIRE / July 26, 202 4/ The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/d/l/press1-2546455.jpg)
Blueprint Medicines Corporation Investors Are Notified By The Schall Law Firm Of Ongoing Investigations Into Possible Securities Law Breaches
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/n/k/press11-2543701.jpg)
Blueprint Medicines Corporation Investors Are Notified By The Schall Law Firm Of Ongoing Investigations Into Possible Securities Law Breaches
LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/6/7/press1-2534704.jpg)
Blueprint Medicines Corporation Investors Are Informed By The Schall Law Firm Of Ongoing Investigations Into Possible Securities Law Breaches
LOS ANGELES, CA / ACCESSWIRE / July 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/n/u/press8-2532922.jpg)
The Schall Law Firm Is Currently Investigating Potential Violations Of Securities Laws For Investors Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / July 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/y/y/conf7-2531246.jpg)
Blueprint Medicines to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
CAMBRIDGE, Mass. , July 18, 2024 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live conference call and webcast at 8:00 a.m.
![](https://cdn.snapi.dev/images/v1/r/g/press2-2529892.jpg)
The Schall Law Firm Is Presently Probing Possible Breaches Of Securities Laws For Blueprint Medicines Corporation Investors
LOS ANGELES, CA / ACCESSWIRE / July 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/6/e/press14-2523279.jpg)
The Schall Law Firm Is At Present Conducting An Inquiry Into Possible Breaches Of Securities Laws For Blueprint Medicines Corporation Investors
LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/q/n/press15-2522783.jpg)
The Schall Law Firm Is Currently Investigating Potential Violations Of Securities Laws For Investors In Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/j/g/press2-2520470.jpg)
Currently The Schall Law Firm Is Investigating Potential Violations Of Securities Laws For Shareholders Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / July 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/y/x/press17-2518112.jpg)
At Present The Schall Law Firm Is Probing Possible Breaches Of Securities Laws For Shareholders Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / July 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/q/p/press10-2515787.jpg)
Currently The Schall Law Firm Is Investigating Potential Violations Of Securities Laws For Blueprint Medicines Corporation Shareholders
LOS ANGELES, CA / ACCESSWIRE / July 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicine...
![](https://cdn.snapi.dev/images/v1/g/d/press13-2513349.jpg)
The Schall Law Firm Is At Present Probing Possible Breaches Of Securities Laws For Shareholders Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / July 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicine...
![](https://cdn.snapi.dev/images/v1/x/f/press12-2511939.jpg)
The Schall Law Firm Is Now Probing Possible Infringements Of Securities Laws For Investors Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / July 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicine...
![](https://cdn.snapi.dev/images/v1/o/l/press12-2511633.jpg)
The Schall Law Firm Is Currently Investigating Potential Violations Of Securities Laws For Stakeholders Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / July 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicine...
![](https://cdn.snapi.dev/images/v1/s/h/press13-2511132.jpg)
The Schall Law Firm Is Presently Probing Possible Breaches Of Securities Laws For Shareholders Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / July 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicine...
![](https://cdn.snapi.dev/images/v1/0/l/press20-2508903.jpg)
Potential Securities Law Violations For Shareholders Of Blueprint Medicines Corporation Are Currently Under Investigation By The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicine...
![](https://cdn.snapi.dev/images/v1/5/8/press16-2507206.jpg)
The Schall Law Firm Is Currently Probing Potential Securities Law Breaches For Shareholders Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicine...
![](https://cdn.snapi.dev/images/v1/c/z/press13-2505052.jpg)
At The Moment The Schall Law Firm Is Scrutinizing Possible Securities Law Violations For Investors of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / July 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicine...
![](https://cdn.snapi.dev/images/v1/6/l/press20-2503754.jpg)
Now The Schall Law Firm Is Looking Into Potential Breaches Of Securities Laws For Stockholders Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / June 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/c/4/press3-2503359.jpg)
At This Time The Schall Law Firm Is Examining Potential Infringements Of Securities Laws For Equity Holders Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / June 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/x/g/press14-2502186.jpg)
Currently The Schall Law Firm Is Investigating Possible Securities Law Breaches For Shareholders Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/h/x/press18-2500489.jpg)
Currently The Schall Law Firm Is Investigating Possible Violations Of Securities Laws For Shareholders Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / June 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/2/w/press5-2498224.jpg)
At Present The Schall Law Firm Is Probing Potential Securities Law Violations For Stock Owners Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...
![](https://cdn.snapi.dev/images/v1/z/z/press14-2495878.jpg)
The Schall Law Firm Is At Present Investigating Possible Breaches Of Securities Laws For Shareholders Of Blueprint Medicines Corporation
LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medicin...